$70.47
2.313.39%
At Close: -
$70.56
0.090.13%
After Hours: Sep 20, 7:39 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Viking Therapeutics (NASDAQ:VKTX) Stock
Viking Therapeutics Stock (NASDAQ: VKTX)
Categories: All
Tuesday, September 17, 2024
Thursday, September 12, 2024
Wednesday, September 11, 2024
Monday, September 09, 2024
Friday, September 06, 2024
Thursday, September 05, 2024
Wednesday, September 04, 2024
Tuesday, September 03, 2024
Thursday, August 29, 2024
Friday, August 23, 2024
Wednesday, August 21, 2024
Tuesday, August 20, 2024
Monday, August 19, 2024
Monday, August 12, 2024
Friday, August 09, 2024
Monday, August 05, 2024
Thursday, August 01, 2024
Tuesday, July 30, 2024
Sunday, July 28, 2024
Friday, July 26, 2024
Thursday, July 25, 2024
- Novo Nordisk Shares Decline Amid Competitive Pressure
- Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
- Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
- Raymond James Maintains Strong Buy on Viking ...
- Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
- IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
- Why Eli Lilly and Company Shares Are Moving Lower On Thursday
- Viking Therapeutics shares are trading higher...
- HC Wainwright & Co. Reiterates Buy on Viking ...
- Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wednesday, July 24, 2024
Tuesday, July 23, 2024
Thursday, July 18, 2024
Wednesday, July 17, 2024
- Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Viking Therapeutics shares are trading lower ...
- Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
- Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'